CGS in the News

A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer, obesity, autism, bipolar disorder, even celiac disease. These conditions are informed by many genetic variants and environmental factors - so...

Halt sign
By Farah Qaiser, Forbes [cites CGS' Marcy Darnovsky] | 10.31.2020

In a new study, four researchers reviewed policy documents from 106 countries to map out the policy landscape regarding...

scissors cutting DNA
By Amy Dockser Marcus, Wall Street Journal [cites CGS' Marcy Darnovsky] | 10.29.2020

Scientists using the Crispr gene-editing technology in human embryos to try to repair a gene that causes hereditary blindness found it...

By Jude Casimir, Wear Your Voice [cites CGS' Marcy Darnovsky] | 10.27.2020

Henrietta Lacks visited John Hopkins Hospital in 1951, complaining of vaginal bleeding. A mother of five children, Lacks was diagnosed by gynecologist...

Stem cell under microscope
By Rachel Bluth, California Healthline [cites CGS' Marcy Darnovsky] | 10.21.2020

SACRAMENTO — In an election year dominated by a chaotic presidential race and splashy statewide ballot initiative campaigns, Californians are...

Voting by mail
By Terry McSweeney, NBC Bay Area [cites CGS' Marcy Darnovsky] | 10.04.2020

Proposition 14 on the November ballot asks voters to approve $5.5 billion to continue funding stem cell research in California...

Home DNA testing
By Caitlin Harrington, Wired [cites CGS' Katie Hasson] | 10.02.2020

WHEN THE GENEALOGY company Ancestry released the latest update to its “ethnicity estimates” last month, a lot of people suddenly became...

2020 elections
By Guardian Editorial, San Francisco Bay Guardian [cites CGS] | 10.01.2020

We were for Bernie. We think he would have won in 2016 and would win this year.

But it’s not...

An embryonic stem cell
By Sammy Caiola, CapRadio [cites Center for Genetics and Society] | 09.18.2020

A measure on the November ballot would allow California to issue $5.5 billion in bonds to fund stem cell research...